Skip to main content
SpringerLink
Log in

The role of nebulized inhaled corticosteroid therapy in adult patients with asthma and chronic obstructive pulmonary disease

  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

Conventional metered-dose inhalers and dry powder inhalers are used by most adult patients with asthma and chronic obstructive pulmonary disease who receive inhaled corticosteroid therapy. There are circumstances, however, in which nebulized inhaled corticosteroid delivery may provide greater clinical benefit to these patients. This review discusses the efficacy and safety of nebulized inhaled corticosteroid therapy in adult patients with asthma or chronic obstructive pulmonary disease for whom nebulized therapy may be preferable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. National Asthma Education and Prevention Program. Expert panel report: guidelines for the diagnosis and management of asthma. Update on selected topics—2002. J Allergy Clin Immunol. 2002;110(5 suppl):S141-S219.

    Article  Google Scholar 

  2. Global Initiative for Chronic Obstructive Lung Disease™. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Executive Summary. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health; 2003.

    Google Scholar 

  3. American Thoracic Society. Management of Stable COPD: Pharmacological Therapy. Available at: http://www.thoracic.org/COPD/6/glucocorticoids.asp. Accessed on: August 23, 2004.

  4. Allen SC, Jain M, Ragab S, Malik N. Acquisition and short-term retention of inhaler techniques requiring intact executive function in elderly subjects. Age Ageing. 2003;32:299–302.

    Article  PubMed  Google Scholar 

  5. Gray SL, Williams DM, Pulliam CC, Sirgo MA, Bishop AL, Donohue JF. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch Intern Med. 1996;156:984–988.

    Article  PubMed  CAS  Google Scholar 

  6. O’Donohue WJ and the National Association for Medical Direction of Respiratory Care Consensus Group. Guidelines for the use of nebulizers in the home and at domiciliary sites. Report of a consensus conference. Chest. 1996;109:814–820.

    Article  PubMed  Google Scholar 

  7. Demoly P, Jaffuel D, Sahla H, Bousquet J, Michel F-B, Godard P. The use of home nebulizers in adult asthma. Respir Med. 1998;92:624–627.

    Article  PubMed  CAS  Google Scholar 

  8. Dahlström K, Thorson L, Larsson P, Nikander K. Systematic availability and lung deposition of budesonide via three different nebulizers in adults. Ann Allergy Asthma Immunol. 2003;90: 226–232.

    Article  PubMed  Google Scholar 

  9. Szefler SJ, Eigen H. Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma. J Allergy Clin Immunol. 2002;109:730–742.

    Article  PubMed  Google Scholar 

  10. Pulmicort Turbuhaler® [package insert]. Wilmington, Del: AstraZeneca LP; September 2004.

  11. Edsbacker S, Brattsand R. Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available data. Ann Allergy Asthma Immunol. 2002;88:609–616.

    PubMed  Google Scholar 

  12. Pulmicort Respules® [package insert]. Wilmington, Del: AstraZeneca LP; September 2004.

  13. Flixotide™ Nebules™ [package insert]. Uxbridge, Middlesex, UK: Glaxo Wellcome UK Ltd; March 2003.

  14. Dempsey OJ, Humphreys M, Coutie WJR, Lipworth BJ. Relative lung delivery of fluticasone propionate via large volume spacer or nebuliser in healthy volunteers. Eur J Clin Pharmacol. 2001;57:637–641.

    PubMed  CAS  Google Scholar 

  15. Connolly KC, Peake PD, Halpin DMG, Golightly L, Turbitt ML. Challenging current asthma treatment guidelines. Improved control of asthma symptoms with nebulized budesonide in patients with severe asthma receiving continuous oral steroids. Dis Manag Health Outcomes. 2000;7:217–225.

    Article  Google Scholar 

  16. Otulana BA, Varma N, Bullock A, Higenbottam T. High dose nebulized steroid in the treatment of chronic steroid-dependent asthma. Respir Med. 1992;86:105–108.

    Article  PubMed  CAS  Google Scholar 

  17. Higenbottam TW, Clark RA, Luksza AR, et al. The role of nebulized budesonide in permitting a reduction in the dose of oral steroid in persistent severe asthma. Eur J Clin Res. 1994;5:1–10.

    Google Scholar 

  18. O’Connor BJ, Barsan GS, O’Connell F, O’Shaughnessy KM. Oral steroid sparing effect of nebulized budesonide in chronic severe asthma. Am J Respir Crit Care Med. 1996;153:A341.

    Google Scholar 

  19. Westbroek J, Saarelainen S, Laher M, O’Brien J, Barnacle H, Efthimiou J. Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma. Respir Med. 1999;93:689–699.

    Article  PubMed  CAS  Google Scholar 

  20. Gawchik SM. Successful treatment of previously uncontrolled adult asthma with budesonide inhalation suspension (Pulmicort Respules®) [abstract]. Ann Allergy Asthma Immunol. 2002;88:97. Abstract 75.

    Google Scholar 

  21. Berman GD, Rockey C. Nebulized budesonide inhalation suspension (Pulmicort Respules®) improves asthma control and quality of life in an adult cerebral palsy patient unable to use metered-dose inhalers [abstract]. Ann Allergy Asthma Immunol. 2003;90:103. Abstract 26.

    Google Scholar 

  22. Higenbottam TW, Britton J, Lawrence D, et al, on behalf of the Pulmicort Respules Versus Oral Steroids: A Prospective Clinical Trial in Acute Asthma (PROSPECTS): ADULT study team. Comparison of nebulized budesonide and prednisolone in severe asthma exacerbations in adults. Bio Drugs. 2000;14:247–254.

    CAS  Google Scholar 

  23. Morice AH, Morris D, Lawson-Matthew P. A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease. Clin Pharmacol Ther. 1996;60:675–678.

    Article  PubMed  CAS  Google Scholar 

  24. Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;165:698–703.

    PubMed  Google Scholar 

  25. Sharma PK, Malhotra S, Pandhi P, Kumar N. Effect of inhaled steroids on bone mineral density: a meta-analysis. J Clin Pharmacol. 2003;43:193–197.

    Article  PubMed  CAS  Google Scholar 

  26. Jones A, Fay JK, Burr M, Stone M, Hood K, Roberts G. Inhaled corticosteroid effect on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002; CD003537.

  27. Richy F, Bousquet J, Ehrlich GE, et al. Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review. Osteoporos Int. 2003;14:179–190.

    PubMed  CAS  Google Scholar 

  28. Wilson AM, McFarlane LC, Lipworth BJ. Systemic bioactivity profiles of oral prednisolone and nebulized budesonide in adult asthmatics. Chest. 1998;114:1022–1027.

    Article  PubMed  CAS  Google Scholar 

  29. Cruz-Rivera M, Lyzell E, Fitzpatrick S. Low frequency of adverse events reported through postmarketing surveillance for Pulmicort Respules® (budesonide inhalation suspension) in the US adult population [abstract]. J Allergy Clin Immunol. 2002;109(suppl):S292. Abstract 895.

    Article  Google Scholar 

  30. Lyzell E, Cruz-Rivera M, Fitzpatrick S. Safety of Pulmicort Respules® (budesonide inhalation suspension) in geriatric patients: postmarketing surveillance and clinical study data [abstract]. J Allergy Clin Immunol. 2002;109(suppl):S292. Abstract 894.

    Article  Google Scholar 

  31. Källén B, Rydhstroem H, Åberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol. 1999;93:392–395.

    Article  PubMed  Google Scholar 

  32. Ericson A, Källén B. Use of drugs during pregnancy-unique Swedish registration method that can be improved. Information From the Swedish Medical Products Agency. 1999;1:8–11.

    Google Scholar 

  33. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis. 1993;148:S1-S26.

    PubMed  CAS  Google Scholar 

  34. Nikander K, Turpeinen M, Wollmer P. The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension. J Aerosol Med. 1999;12:47–53.

    PubMed  CAS  Google Scholar 

  35. Smaldone GC, Crus-Rivera M, Nikander K. In vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspension. J Aerosol Med. 1998;11:113–125.

    Article  Google Scholar 

  36. Barry PW, O’Callaghan C. An in vitro analysis of the output of budesonide from different nebulizers. J Allergy Clin Immunol. 1999;104:1168–1173.

    Article  PubMed  CAS  Google Scholar 

  37. Bisgaard H, Nikander K, Munch E. Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics. Respir Med. 1998;92:44–49.

    Article  PubMed  CAS  Google Scholar 

  38. McKenzie JE, Cruz-Rivera M. Compatibility of budesonide inhalation suspension with four nebulizing solutions. Ann Pharmacother. 2004;38:967–972.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Curriculum Development, New York College of Osteopathic Medicine of New York Institute of Technology, Old Westbury, NY

    Philip Marcus MD, MPH (Clinical Professor of Medicine and Associate Dean, Chief)

  2. Division of Pulmonary Medicine, St. Francis Hospital, Roslyn, NY

    Philip Marcus MD, MPH (Clinical Professor of Medicine and Associate Dean, Chief)

Authors
  1. Philip Marcus MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marcus, P. The role of nebulized inhaled corticosteroid therapy in adult patients with asthma and chronic obstructive pulmonary disease. Adv Therapy 22, 407–418 (2005). https://doi.org/10.1007/BF02850087

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02850087

Keywords

Search

Navigation